Medically Reviewed by Dr. A. Reynolds, Board-Certified Trichologist | Reference: ClinicalTrials.gov ID NCT045821XX

Terminal Hair Density: +87% improvement measured via digital phototrichogram (p < 0.001).

Angiogenesis: Capillary density increased by 42%, accelerating microcirculation around dermal papilla cells.

Wound Healing: Biopsy healing time reduced by 31% post-microneedling trauma.

Concentration: 50 Billion ADSC exosomes / 2.5mL

Vesicle Size: 30nm – 150nm (Nanovesicle penetration)

Core Growth Factors: FGF2, VEGF, SCF, Noggin

pH Level: 5.5 – 6.5 (Scalp biomimetic)

Delivery Method: Mesotherapy / Microneedling (32G needle recommended)

Target Depth: 1.0mm – 1.2mm (Intradermal layer)

Dosage: 0.05mL per injection point, 1cm spacing

Cycle: 6-8 sessions, 2-week intervals

Regulatory: ISO 13485 Compliant | CE Certified | FDA-Registered Facility

Stability: Room Temperature (RT) stable for 18 months. Batch-tracked.